These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7578329)

  • 21. Some long-term effects of exchange transfusion with fluorocarbon emulsions in macaque monkeys.
    Rosenblum WI; Moncure CW; Behm FG
    Arch Pathol Lab Med; 1985 Apr; 109(4):340-4. PubMed ID: 3838643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK; Aprosin UD; Afonin NI
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The kinetic characteristics of drugs in the presence of perfluorocarbon blood substitutes].
    Lutsevich AN; Tsareva EIu
    Eksp Klin Farmakol; 1992; 55(3):74-7. PubMed ID: 1458174
    [No Abstract]   [Full Text] [Related]  

  • 24. Drop size stability assessment of fluorocarbon emulsions.
    Krafft MP; Postel M; Riess JG; Ni Y; Pelura TJ; Hanna GK; Song D
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):865-8. PubMed ID: 1391525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-life of perfluorooctylbromide in inner organs determined by fast 19F-NMR imaging.
    Jäger LJ; Nöth U; Haase A; Lutz J
    Adv Exp Med Biol; 1994; 361():129-34. PubMed ID: 7597935
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T; Lenz C; Waschke KF
    Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
    [No Abstract]   [Full Text] [Related]  

  • 28. Replacement of red cell functions by cyclic fluorocarbon emulsions.
    Clark LC; Moore R
    Prog Clin Biol Res; 1981; 55():595-608. PubMed ID: 7291199
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of emulsion concentration on biodistribution of perflubron in tumor-bearing mice.
    Long DM; Witt BL; Escobar JA; Long RA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):907-10. PubMed ID: 1391531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of fluorocarbon emulsion on the cardiovascular system].
    Chen WZ; Li HQ; Shen YT; Dong YL; Ding XC
    Yao Xue Xue Bao; 1986 Feb; 21(2):86-91. PubMed ID: 3751596
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of viscosity on instilled perfluorocarbon distribution in rabbit lungs.
    Tredici S; Tredici F; Brant DO; Hirschl RB; Bull JL
    J Biomech Eng; 2006 Dec; 128(6):857-61. PubMed ID: 17154686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improvement of cardiac systolic function in myocardial ischemic rabbit by hemodilution with fluorocarbon emulsion].
    Ma XL; Zhao RR; Zang YM; Wang FZ
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):73-6. PubMed ID: 3188939
    [No Abstract]   [Full Text] [Related]  

  • 33. Stabilization of perflubron emulsions with egg yolk phospholipid.
    Pelura TJ; Johnson CS; Tarara TE; Weers JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):845-8. PubMed ID: 1391521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some aspects of perfluorochemical emulsion's interaction with blood.
    Tereshina EV; Doronina NN; Afonin NI; Ozerova IN; Tcherbacova IA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1001-11. PubMed ID: 1391418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood plasma protein adsorption capacity of perfluorocarbon emulsion stabilized by proxanol 268 (in vitro and in vivo studies)].
    Sklifas AN; Zhalimov VK; Temnov AA; Kukushkin NI
    Biofizika; 2012; 57(2):317-24. PubMed ID: 22594289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging.
    Meyer KL; Carvlin MJ; Mukherji B; Sloviter HA; Joseph PM
    Invest Radiol; 1992 Aug; 27(8):620-7. PubMed ID: 1428740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfluoroalklylated phospholipids as surfactants and co-surfactants forinjectable fluorocarbon emulsions.
    Santaella C; Vierling P; Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):835-7. PubMed ID: 1391518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
    Gross U; Rüdiger S; Reichelt H; Draffehn J
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):831-3. PubMed ID: 1391517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR).
    Zarif L; Postel M; Septe B; Trevino L; Riess JG; Mahé AM; Follana R
    Pharm Res; 1994 Jan; 11(1):122-7. PubMed ID: 8140043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emulsions of perfluorinated solvents for intravascular gas transport.
    Clark LC; Wesseler EP; Kaplan S; Miller ML; Becker C; Emory C; Stanley L; Becattini F; Obrock V
    Fed Proc; 1975 May; 34(6):1468-77. PubMed ID: 1126444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.